Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Facebook
Linkedin
Twitter
Home
R&D
FINANCE
MANUFACTURING
APPROVALS
SUPPLY CHAIN
LAUNCHES
EVENTS
EVENTS NEWS
EVENT LISTINGS
APPOINTMENTS
Search
Home
Featured
Page 142
Featured
Featured posts
Featured posts
Latest
Featured posts
Most popular
7 days popular
By review score
Random
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
BridgeBio’s BEYONTTRA approved by European Commission to treat ATTR-CM
UK unveils funding for AI companies to transform cancer care and spark new drug breakthroughs
Pacira BioSciences boosts non-opioid pain management position with Flexion acquisition
13th October 2021
ACG Make it Better Event: Demystifying pharma packaging regulations now and...
12th October 2021
Ipsen taps Novartis talent for new Specialty Care International president
12th October 2021
Merck submits EUA in the US for molnupiravir
11th October 2021
Sandoz completes acquisition of GSK’s cephalosporin antibiotics business
11th October 2021
Humanigen signs contract with Clinigen for Lenzilumab Managed Access Program in...
11th October 2021
Entia rases £12m to launch virtual oncology solution
11th October 2021
Brii Bio files EUA application with FDA for investigational SARS-CoV-2 combination...
11th October 2021
Enzolytics and Samsung Biologics to manufacture monoclonal antibody therapies
8th October 2021
Historic moment as WHO recommends groundbreaking malaria vaccine for children
8th October 2021
1
...
141
142
143
...
146
Page 142 of 146
News
AbbVie and Xilio Therapeutics to develop novel tumor-activated immunotherapies
14th February 2025
AbbVie and Xilio Therapeutics, a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies for people living with cancer, have announced a collaboration and...
Duchenne muscular dystrophy market to reach $5.2 billion in 7MM by 2033, forecasts GlobalData
14th February 2025
The Duchenne muscular dystrophy (DMD) market across the seven major markets (7MM*) is set to grow from $2.3 billion in 2023 to $5.2 billion...
Royalty Pharma to provide $250m R&D funding in Biogen lupus collaboration
13th February 2025
Royalty Pharma has entered into an agreement with Biogen to provide research and development (R&D) funding of up to $250 million for litifilimab, a...